<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36066624</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>270</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Co-occurrence of amyotrophic lateral sclerosis and Leber's hereditary optic neuropathy: is mitochondrial dysfunction a modifier?</ArticleTitle><Pagination><StartPage>559</StartPage><EndPage>564</EndPage><MedlinePgn>559-564</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11355-w</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amore</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vacchiano</LastName><ForeName>Veria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Morgia</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentino</LastName><ForeName>Maria L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caporali</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorini</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ormanbekova</LastName><ForeName>Danara</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salvi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma SLA Atassia Amiloidosi e Miastenia, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoletti-Stella</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental, Diagnostic and Specialty Medicine, DIMES University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capellari</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liguori</LastName><ForeName>Rocco</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carelli</LastName><ForeName>Valerio</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-4923-6404</Identifier><AffiliationInfo><Affiliation>Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy. valerio.carelli@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy. valerio.carelli@unibo.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bellaria Hospital, Via Altura 3, 40139, Bologna, Italy. valerio.carelli@unibo.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029242" MajorTopicYN="Y">Optic Atrophy, Hereditary, Leber</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>CLM received consultancies fees from Chiesi Farmaceutici, Regulatory Pharma Net and Thenewway srl, speaker honoraria from Santhera Pharmaceuticals, Chiesi Farmaceutici, Regulatory Pharma Net, Thenewway srl, First Class srl and Biologix, and travel support from Santhera Pharmaceuticals. LC received speaker honoraria from First Class srl and University of Parma. RL received speaker honoraria and travel support from Amicus Therapeutics srl, Editree srl, LT3 srl, PTS srl, Planning Congressi srl, Galen Symposion srl, and participates into the advisory board of Argenx BV, Alexion Pharma Italy srl, UCB Pharma spa and Prex srl. VC received consultancies fees from Chiesi Farmaceutici and Pretzel Therapeutics and speaker honoraria from Chiesi Farmaceutici and First Class srl.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>6</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36066624</ArticleId><ArticleId IdType="pmc">PMC9813087</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11355-w</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11355-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;25(710):132933. doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Carelli V, Chan DC. Mitochondrial DNA: impacting central and peripheral nervous systems. Neuron. 2014;84(6):1126&#x2013;1142. doi: 10.1016/j.neuron.2014.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.11.022</ArticleId><ArticleId IdType="pmc">PMC4271190</ArticleId><ArticleId IdType="pubmed">25521375</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporali L, Iommarini L, La Morgia C, Olivieri A, Achilli A, Maresca A, Valentino ML, Capristo M, Tagliavini F, Del Dotto V, Zanna C, Liguori R, Barboni P, Carbonelli M, Cocetta V, Montopoli M, Martinuzzi A, Cenacchi G, De Michele G, Testa F, Nesti A, Simonelli F, Porcelli AM, Torroni A, Carelli V. Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber&#x2019;s hereditary optic neuropathy. PLoS Genet. 2018;14(2):e1007210. doi: 10.1371/journal.pgen.1007210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007210</ArticleId><ArticleId IdType="pmc">PMC5828459</ArticleId><ArticleId IdType="pubmed">29444077</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497&#x2013;50318164242. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoletti-Stella A, Vacchiano V, De Pasqua S, Mengozzi G, De Biase D, Bartolomei I, Avoni P, Rizzo G, Parchi P, Donadio V, Chi&#xf2; A, Pession A, Oppi F, Salvi F, Liguori R, Capellari S, BoReALS Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum. J Neurol. 2021 doi: 10.1007/s00415-021-10521-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10521-w</ArticleId><ArticleId IdType="pmc">PMC8463338</ArticleId><ArticleId IdType="pubmed">33770234</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt V, Morrison PJ, Crushell E, Donnelly DE, Alston CL, He L, McFarland R, Taylor RW. The clinical spectrum of the m.10191T&gt;C mutation in complex I-deficient Leigh syndrome. Dev Med Child Neurol. 2012;54(6):500&#x2013;506. doi: 10.1111/j.1469-8749.2012.04224.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-8749.2012.04224.x</ArticleId><ArticleId IdType="pubmed">22364517</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifati V, Roh&#xe9; CF, Breedveld GJ, Fabrizio E, De Mari M, Tassorelli C, Tavella A, Marconi R, Nicholl DJ, Chien HF, Fincati E, Abbruzzese G, Marini P, De Gaetano A, Horstink MW, Maat-Kievit JA, Sampaio C, Antonini A, Stocchi F, Montagna P, Toni V, Guidi M, Dalla Libera A, Tinazzi M, De Pandis F, Fabbrini G, Goldwurm S, de Klein A, Barbosa E, Lopiano L, Martignoni E, Lamberti P, Vanacore N, Meco G, Oostra BA, Italian Parkinson Genetics Network Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology. 2005;65(1):87&#x2013;95. doi: 10.1212/01.wnl.0000167546.39375.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000167546.39375.82</ArticleId><ArticleId IdType="pubmed">16009891</ArticleId></ArticleIdList></Reference><Reference><Citation>Debska-Vielhaber G, Miller I, Peeva V, Zuschratter W, Walczak J, Schreiber S, Petri S, Machts J, Vogt S, Szczepanowska J, Gellerich FN, Hermann A, Vielhaber S, Kunz WS. Impairment of mitochondrial oxidative phosphorylation in skin fibroblasts of SALS and FALS patients is rescued by in vitro treatment with ROS scavengers. Exp Neurol. 2021;23(339):113620. doi: 10.1016/j.expneurol.2021.113620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113620</ArticleId><ArticleId IdType="pubmed">33497646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodavati M, Wang H, Hegde ML. Altered mitochondrial dynamics in motor neuron disease: an emerging perspective. Cells. 2020;9(4):1065. doi: 10.3390/cells9041065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9041065</ArticleId><ArticleId IdType="pmc">PMC7226538</ArticleId><ArticleId IdType="pubmed">32344665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano M, Angelini C, Montagna P, Hays AP, Tanji K, Mitsumoto H, Gordon PH, Naini AB, DiMauro S, Rowland LP. Amyotrophic lateral sclerosis with ragged-red fibers. Arch Neurol. 2008;65(3):403&#x2013;406. doi: 10.1001/archneurol.2007.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2007.65</ArticleId><ArticleId IdType="pubmed">18332255</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano C, Iommarini L, Giordano L, Maresca A, Pisano A, Valentino ML, Caporali L, Liguori R, Deceglie S, Roberti M, Fanelli F, Fracasso F, Ross-Cisneros FN, D'Adamo P, Hudson G, Pyle A, Yu-Wai-Man P, Chinnery PF, Zeviani M, Salomao SR, Berezovsky A, Belfort R, Jr, Ventura DF, Moraes M, Moraes Filho M, Barboni P, Sadun F, De Negri A, Sadun AA, Tancredi A, Mancini M, d'Amati G, LoguercioPolosa P, Cantatore P, Carelli V. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy. Brain. 2014;137(Pt 2):335&#x2013;353. doi: 10.1093/brain/awt343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt343</ArticleId><ArticleId IdType="pmc">PMC3914475</ArticleId><ArticleId IdType="pubmed">24369379</ArticleId></ArticleIdList></Reference><Reference><Citation>Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, Prelle A, Fortunato F, Zeviani M, Napoli L, Bresolin N, Moggio M, Ausenda CD, Taanman JW, Scarlato G. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol. 1998;43(1):110&#x2013;116. doi: 10.1002/ana.410430119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410430119</ArticleId><ArticleId IdType="pubmed">9450776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore DG, Verschueren A, Rouzier C, BerI Le, Aug&#xe9; G, Cochaud C, Lespinasse F, N&#x2019;Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, Paquis-Flucklinger V. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137(Pt 8):2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Schmid B, Nikolaisen NK, Rasmussen MA, Aldana BI, Agger M, Calloe K, Stummann TC, Larsen HM, Nielsen TT, Huang J, Xu F, Liu X, Bolund L, Meyer M, Bak LK, Waagepetersen HS, Luo Y, Nielsen JE, FReJA Consortium, Holst B, Clausen C, Hyttel P, Freude KK Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B. Stem Cell Reports. 2017;8(3):648&#x2013;658. doi: 10.1016/j.stemcr.2017.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.01.012</ArticleId><ArticleId IdType="pmc">PMC5355623</ArticleId><ArticleId IdType="pubmed">28216144</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Sipos J, Thau-Habermann N, K&#xf6;rner S, Rath KJ, Dengler R, Petri S. Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model. J Neuropathol Exp Neurol. 2013;72(11):1052&#x2013;1061. doi: 10.1097/NEN.0000000000000004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000004</ArticleId><ArticleId IdType="pubmed">24128678</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van der Spek RAA, Bakker MK, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53(12):1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G, Burke A, Yu-Wai-Man P, Compston DA, Chinnery PF. Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations. Neurology. 2013;81(24):2073&#x2013;2081. doi: 10.1212/01.wnl.0000437308.22603.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000437308.22603.43</ArticleId><ArticleId IdType="pmc">PMC3863351</ArticleId><ArticleId IdType="pubmed">24198293</ArticleId></ArticleIdList></Reference><Reference><Citation>Danese A, Patergnani S, Maresca A, Peron C, Raimondi A, Caporali L, Marchi S, La Morgia C, Del Dotto V, Zanna C, Iannielli A, Segnali A, Di Meo I, Cavaliere A, Lebiedzinska-Arciszewska M, Wieckowski MR, Martinuzzi A, Moraes-Filho MN, Salomao SR, Berezovsky A, Belfort R, Jr, Buser C, Ross-Cisneros FN, Sadun AA, Tacchetti C, Broccoli V, Giorgi C, Tiranti V, Carelli V, Pinton P. Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy. Cell Rep. 2022;40(3):111124. doi: 10.1016/j.celrep.2022.111124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111124</ArticleId><ArticleId IdType="pmc">PMC9314546</ArticleId><ArticleId IdType="pubmed">35858578</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A, Angelini C. Microglia polarization by mitochondrial metabolism modulation: a therapeutic opportunity in neurodegenerative diseases. Mitochondrion. 2019;46:334&#x2013;336. doi: 10.1016/j.mito.2018.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2018.09.003</ArticleId><ArticleId IdType="pubmed">30243831</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol. 2022 doi: 10.1038/s41577-022-00760-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00760-x</ArticleId><ArticleId IdType="pmc">PMC9310369</ArticleId><ArticleId IdType="pubmed">35879417</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, Manera U, Canosa A, Grassano M, Palumbo F, Cugnasco P, De Marchi F, Mazzini L, Calvo A, Chi&#xf2; A. What is amyotrophic lateral sclerosis prevalence? Amyotroph Lateral Scler Frontotemporal Degener. 2021;21:1&#x2013;6. doi: 10.1080/21678421.2021.1936557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2021.1936557</ArticleId><ArticleId IdType="pubmed">34151660</ArticleId></ArticleIdList></Reference><Reference><Citation>Amore G, Romagnoli M, Carbonelli M, Barboni P, Carelli V, La Morgia C. Therapeutic options in hereditary optic neuropathies. Drugs. 2021;81(1):57&#x2013;86. doi: 10.1007/s40265-020-01428-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-020-01428-3</ArticleId><ArticleId IdType="pmc">PMC7843467</ArticleId><ArticleId IdType="pubmed">33159657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>